The potential role of cannabinoids (CBD, CBG, etc) as antitumoral drugs is being explored in relation to the inflammatory component of skin cancer.
In vivo and in vitro studies that employed either phyto-, endo-, or synthetic cannabinoids show promise in topical treatment of Skin Cancer.
Cannabinoids are regarded with growing interest as eligible drugs in the treatment of skin inflammatory conditions with potential anticancer effects.
Topical CBD was also found effective in alleviating the symptoms of the following conditions: oxidative stress on dermal cells, skin conditions characterized by inflammation and keratin disorders, such as eczema or atopic dermatitis, wound healing, pain & muscle relief, itch (pruritis), Acne/Seborrhea, modulation of hair growth, skin & hair pigmentation, oral care, and other skin disorders such as antibiotic-resistant skin infections, cutaneous malignancies such as Melanoma, and Psoriatic Plaques.
Many studies currently report these effects, and the readiness in monitoring of effects and the facility of topical application may contribute to the growing support of the use of these substances. Not medical advice.
Shop Our Lab-Tested, Pharmacist- Formulated Full Spectrum Oils Now!